The Supreme Court's latest decision regarding human genes is that
naturally occurring DNA is not patent eligible. At the same time,
synthetically created DNA, known as a cDNA, is patent eligible. Click
to read Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. ___, 2013 WL 2631062 (2013).
For more information about this case, click on these links:
SCOTUS Blog
Oyez Project
Huffington Post
Recent law review and journal articles on biotechnology and patent law can be found in the following resources:
Duke Law and Technology Review (free online legal publication)
Harvard Journal of Law and Technology (JOLT) and its companion publication, JOLT Digest (free online legal publications)
Marquette Intellectual Property Law Review (free online legal publication)
IDEA: The Intellectual Property Law Review (available in Hein Online subscription database)
Nanotechnology Law and Business (available in Hein Online subscription database)
(This entry was originally written and posted by Gordana Filipovic)
No comments:
Post a Comment